Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|September 26, 2019
Changing Body Weight-Based Dosing to a Flat Dose for Avelumab in Metastatic Merkel Cell and Advanced Urothelial CarcinomaAna M Novakovic, Justin J Wilkins, Haiqing Dai, et al.
Urology|May 18, 2010
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumorBenoit You, Ludivine Fronton, Helen Boyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Model-Based Characterization of the Bidirectional Interaction Between Pharmacokinetics and Tumor Growth Dynamics in Patients with Metastatic Merkel Cell Carcinoma Treated with AvelumabAna-Marija Grisic, Wenyuan Xiong, Lénaïg Tanneau, et al.
Cancer Chemotherapy and Pharmacology|June 30, 2022
Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendationsWenyuan Xiong, Sofia Friberg Hietala, Joakim Nyberg, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 11, 2023
A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancerHan Liu, Ana-Marija Milenković-Grišić, Sreenath M Krishnan, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 31, 2021
Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumabNadia Terranova, Jonathan French, Haiqing Dai, et al.
Clinical Biochemistry|April 29, 2008
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomyBenoit You, Paul Perrin, Gilles Freyer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Predictors of prescription errors involving anticancer chemotherapy agentsFlorence Ranchon, Céline Moch, Benoît You, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 14, 2019
Time-Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial CarcinomaJustin J Wilkins, Brigitte Brockhaus, Haiqing Dai, et al.
Lung Cancer (Amsterdam, Netherlands)|April 30, 2008
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre studyBenoit You, Brigitte Tranchand, Pascal Girard, et al.
Pageof 9